Clinical Trials Logo

Filter by:
NCT ID: NCT05866250 Completed - Acute Kidney Injury Clinical Trials

Dynamic Change of Doppler-based Renal Resistive Index in Predicting Renal Recovery

DRRRI
Start date: August 1, 2023
Phase:
Study type: Observational [Patient Registry]

The goal of this observational study is to observe the correlation between dynamic changes in the Doppler-based renal resistive index (RI) and the occurrence of persistent acute kidney injury (AKI) in critically ill patients. The main questions it aims to answer are: - Are dynamic changes of RI within 24 or 48 hours associated with the prognosis of AKI (NO AKI, transient AKI, persistent AKI)? - what are the influencing factors of changes in RI? Participants will measure values of RI in patients at admission (0 hour), after 24 hours and after 48 hours, respectively, and collect characters such as age, sex, vital signs, Apache II, diagnosis, renal function, applied drugs, fluid, 72-hour renal function and renal replacement, followed renal replacement and the mortality rate at 28 days.

NCT ID: NCT05866172 Recruiting - Clinical trials for Hepatocellular Carcinoma

HAIC Combined Withzoledronic Acid for the Prevention of Bone Metastases in Advanced HCC

Start date: May 10, 2023
Phase: Phase 3
Study type: Interventional

Zoledronic acid was initially used for bone metastases in various malignancies. However, it is unknown whether hepatic arterial infusion chemotherapy combined with zoledronic acid can improve overall survival of unresectable hepatocellular carcinoma.

NCT ID: NCT05865977 Recruiting - Premature Clinical Trials

dTDI During a SBT to Predict Extubation Failure in Preterm Infants

Start date: February 25, 2023
Phase:
Study type: Observational

Weaning from mechanical ventilation is a critical issue and the diaphragmatic disfunction has been demonstrated to play an important role in extubation failure. the aim of present investigation is to evaluate diaphragmatic excursion velocity during in patients undergoing spontaneous breathing trial through tissue Doppler analysis in both inspiration and expiration.

NCT ID: NCT05865925 Enrolling by invitation - Clinical trials for Advanced Solid Tumors

Safety, Tolerability, Pharmacokinetics (PK), and Primary Clinical Efficacy of LY01616 in Patients With Advanced Solid Tumors

Start date: April 22, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

This is a multicenter, open, dose escalation, single and multiple administration phase Ⅰ/Ⅱ clinical study to evaluate the safety, tolerability, pharmacokinetics (PK), and primary clinical efficacy of LY01616 in patients with advanced solid tumors

NCT ID: NCT05865860 Recruiting - Microsurgery Clinical Trials

Application and Safety Evaluation of 3D Visualization System in Microsurgical Training

Start date: January 1, 2023
Phase:
Study type: Observational

Based on the relative shortage of ophthalmic surgeons in China, the long micromanipulation cycle and the existing micromanipulation training methods have their own limitations, such as traditional operating in porcine eyes limited to synchronous guidance and evaluation, while surgical simulators are very different for the simulation of real tissues, and the price is expensive and easy to lose. Based on these, the development of a digital training system, that is, based on traditional micromanipulation platforms such as animal tissue, physical microscopic instruments supplemented by synchronous surgical guidance and evaluation, can combine the advantages of traditional training and simulator, so as to improve the efficiency of ophthalmic surgeon training, and also provide digital ideas for other disciplines based on traditionally surgical teaching.

NCT ID: NCT05865639 Completed - Sedentary; Aging Clinical Trials

Time Restricted Fasting and Aerobic Exercise Interventions Among Sedentary Adults

Start date: February 1, 2022
Phase: N/A
Study type: Interventional

This project will determine the independent and combined effects of aerobic exercise and time restricted fasting on cardiovascular risks among sedentary middle-aged and elderly adults. The online intervention period will be eight weeks. Before and after the intervention, arterial stiffness, cardiac autonomic nervous, body composition, glucolipid metabolism, sleep and eating habits, inflammatory reaction, sedentary behavior and physical activity level will be measured and compared between groups who are doing either aerobic exercise, time restricted fasting, both aerobic exercise and time restricted fasting, or who are in a control group. Adverse reaction, sleep and eating quality, life quality and adherence to the interventions and hunger/satiety will also be measured.

NCT ID: NCT05865574 Not yet recruiting - Healthy Men Clinical Trials

A Comparative Pharmacokinetic Study to Evaluate Different Manufacturing Batches of BAT1706 Injection

Start date: June 2023
Phase: Phase 1
Study type: Interventional

This is a randomized, double-blind, single-dose, parallel two-arm study to compare the pharmacokinetics, safety, and immunogenicity of BAT1706 Injection from different manufacturing batches (by new process and old process) in healthy male subjects.

NCT ID: NCT05865496 Active, not recruiting - Sinusitis Clinical Trials

A Study to Evaluate 611 in Patients With Chronic Rhinosinusitis With Nasal Polyps

Start date: June 30, 2023
Phase: Phase 2
Study type: Interventional

This study will evaluate the effect and safety of 611 in patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP).

NCT ID: NCT05865366 Not yet recruiting - Clinical trials for Acute Postoperative Pain

Pain Trajectories and Predictors After Noncardiac Surgery in Elderly Patients

Start date: June 1, 2023
Phase:
Study type: Observational

This study will use group-based trajectory modeling to identify the different postoperative pain trajectory groups that exist in a mixed surgical population (non-cardiac surgery) of elderly patients during the first seven days after surgery. The aim of this study is to explore the diversity in the development of postoperative pain among elderly patients and to identify the risk factors for acute pain trajectory after surgery by investigating demographic, psychological, and clinical variables. The predictive effect of different trajectories of early postoperative acute pain on postoperative chronic pain will also be explored.

NCT ID: NCT05865132 Recruiting - Clinical trials for Esophagus Squamous Cell Carcinoma

Palbociclib Combined With Afatinib for Advanced Squamous Carcinoma of Esophagus or Gastroesophageal Junction

Start date: April 6, 2023
Phase: Phase 2
Study type: Interventional

This is a prospective, multicenter, exploratory study. Patients with advanced esophageal or gastro-esophageal junction squamous carcinoma who had progressed on first-line chemotherapy combined with immune checkpoint inhibitors were treated with CDK4/6 inhibitor Palbociclib combined with Afatinib. Dose titration was used to determine the final dose, and objective antitumor efficacy was evaluated every 2 cycles (8 weeks +/- 7 days) according to RECIST 1.1 criteria, until tumor progression, intolerable toxicity, death, or withdrawal of informed consent. The primary endpoint is the objective response rate (ORR).